Editor's Pick
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
Connect with us
Hi, what are you looking for?
Your Divident Investor
- Politics
Pro-life pregnancy centers see client increase after Supreme Court decision: study
‘Radical Left’ shutdown message ignites firestorm as Democrats push for federal probe
UN Security Council backs Trump’s Gaza peace plan after Waltz calls territory ‘hell on earth’
China military reaches ‘war footing’ with new missile silos and advanced AI warfare systems
Raspy-voiced Trump reveals reason he ‘blew my stack’ in heated discussion
- Stock
S&P 500 Breaking Out Again: What This Means for Your Portfolio
S&P 500 Breaking Out Again: What This Means for Your Portfolio
S&P 500 Breaking Out Again: What This Means for Your Portfolio
S&P 500 Breaking Out Again: What This Means for Your Portfolio
S&P 500 Breaking Out Again: What This Means for Your Portfolio
- Investing
Living Plants Offer New Path to Rare Earths Supply, Study Shows
Graphite One Confirms Rare Earth Elements at Alaska Deposit
Rio Tinto and Calix to Partner on Zero Emissions Steel Technology Plant
East Star and Endeavour Mining to Collaborate on Kazakhstan Gold Assets
Gerardo Del Real: Gold, Uranium, Copper and More — Stocks I Like, Why I’m Bullish
- Editor’s Pick
Stock
The S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the index has experienced since...
Politics
Senate Democrats are requesting an investigation into what they say is ‘partisan messaging’ that the Trump administration used on official government websites during the...
Politics
Facilities designed to discourage abortion have seen tens of thousands of additional clients in the wake of the Supreme Court’s landmark Dobbs ruling, according...
Politics
President Donald Trump blamed his hoarse voice on a tense discussion with a foreign nation who attempted to renegotiate the terms of their trade...
Investing
Researchers have documented the first known recovery of naturally formed nanoscale monazite from a living plant, potentially opening up new paths to recover in-demand...
Editor's Pick
Editor's Pick
Editor's Pick
Editor's Pick
Politics
China’s military buildup has reached what a new congressional report calls a ‘war footing,’ with hundreds of new missile silos and expanding nuclear capabilities...
Politics
The U.N. Security Council on Monday adopted a U.S.-backed resolution to end the Gaza war and deploy an international stabilization force after Ambassador Mike...
Investing
Graphite One (TSXV:GPH,OTCQX:GPHOF) announced on November 13 that it has identified rare earth elements (REEs) at its Graphite Creek deposit, located north of Nome,...
Investing
East Star Resources (LSE:EST) and Endeavour Exploration announced they have entered into a binding earn-in and joint venture (JV) agreement to advance gold exploration...
Investing
Rio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO) said on Monday (November 17) that it has signed a joint development agreement with environmental technology company Calix (NYSE:CALX,ASX:CXL) to develop...
Editor's Pick
Walmart announced Friday that longtime CEO Doug McMillon will retire at the end of January — which came as a surprise to some given...
Stock
The S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the index has experienced since...
Editor's Pick
Colleen Hroncich Alexandra Batista was ready to quit teaching. Over the years, she had taught at various schools geared toward autistic children, but she...
Editor's Pick
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets....
Editor's Pick
Colin Grabow On occasion, and increasingly of late, one encounters the argument that libertarians and other free trade/free market types suffer from a blindspot concerning...
Editor's Pick
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated...
